TFS Capital’s Celgene Corp CELG Stock Holding History

TFS Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,531	Closed	-$459K	–	589
2017 Q2	$459K	Sell	3,531 -317	-8%	-$38.8K	0.18%	189
2017 Q1	$479K	Sell	3,848 -8	-0.2%	-$957	0.16%	215
2016 Q4	$446K	Buy	3,856 +1,925	+100%	+$214K	0.12%	303
2016 Q3	$202K	Buy	+1,931	New	+$209K	0.05%	555

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TFS Capital's CELG Position: Q3 2017 in Review

TFS Capital sold out of Celgene Corp (CELG) in Q3 2017, closing a stake of 3,531 shares — an estimated $459K sold.

TFS Capital first reported a position in CELG in Q3 2016 and held it in 4 quarters. The position peaked at $479K in Q1 2017. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

TFS Capital reported no remaining Celgene Corp position as of Q3 2017 after selling out during the quarter.
TFS Capital sold 3,531 Celgene Corp shares in Q3 2017, an estimated $459K.
TFS Capital first reported a position in Celgene Corp in Q3 2016 and held it in 4 quarters.
TFS Capital's Celgene Corp position peaked at $479K in Q1 2017.
1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.